Related Experiment Video

Updated: Aug 18, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

[Platelet activation in unstable angina depending on troponin I concentration]

Anna Maria Butkiewicz1, Violetta Dymicka-Piekarska, Izabela Kemona-Chetnik

  • 1Zaklad Laboratoryjnej Diagnostyki Klinicznej Akademii Medycznej w Bialymstoku. annabutkiewicz@wp.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|April 30, 2005
PubMed

Insights

Beta-thromboglobulin (beta-TG) levels increase with higher myocardial infarction risk, as indicated by troponin I. Beta-TG may help estimate infarction risk in patients with unstable angina.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Context:

  • Platelet activation is a key event in atheromatous plaque rupture and ischemic heart disease.
  • Myocardial ischemia and cardiomyocyte damage elevate troponin I levels.
  • Beta-thromboglobulin (beta-TG) and platelet counts (PLT) reflect in vivo platelet activation.

Purpose:

  • To evaluate the correlation between platelet activation markers (beta-TG and PLT) and troponin I levels in unstable angina patients.
  • To assess the utility of beta-TG as a marker for myocardial infarction risk stratification.

Summary:

  • A study involving 54 unstable angina patients and 26 healthy controls analyzed plasma beta-TG, PLT, and troponin I levels.
  • Significantly elevated beta-TG concentrations were observed in patients with high and very high myocardial infarction risk (troponin I 0.2-1.5 ng/ml and >1.5 ng/ml, respectively) compared to controls.
  • Platelet counts (PLT) were significantly lower only in the high-risk group.

Impact:

  • Plasma beta-TG concentration correlates with myocardial infarction risk, as determined by troponin I levels.
  • Beta-TG emerges as a potentially valuable biomarker for estimating myocardial infarction risk in clinical settings.
  • This research contributes to understanding platelet activation in ischemic heart disease and its diagnostic implications.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...